Licensed U.S. Pet Pharmacy | Verified Pharmacy
Sitewide Sale! 15% OFF! Use Code EPX15 *
Nobivac for Feline 1-HCP + FeLV (25 Doses) - [Vaccine]
Item# N011327
FREE SHIPPING Over $79! * Pet Food & Other Exclusions
- Notice
- Description
- Directions
- Reviews
Notices
Shipping is $36.95 + a $6 surcharge for ice. Your order will ship via Express 1-2 day mail and will be packed in an insulated box with ice packs. Items that are required to ship this method will be listed in the item description. Orders placed after 2:00 PM EST (11:pp AM PST) may not end up being able to ship out the same day.
Restrictions: All foreign orders are ineligible. Free shipping is ineligible.
Note: Vaccine orders are only shipped out on Mon-Wed. due to Express service only being able to deliver during weekdays. We cannot be responsible for vaccine or other refrigerated orders that are delayed because no one is present at the time it is delivered.
Description
Nobivac Feline 1-HCP + FeLV is recommended for the vaccination of health cats as an aid in the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection. Vaccination with this product prevents persistent viremia in cats exposed to virulent feline leukemia virus. The fleine leukemia virus, The feline leukemia virus, subgroups A and B, are cultured in tissue culture cells. The virus has been chemically inactivated and combined with a proprietary adjuvant designed to enhance the immune response.
- Features & Benefits
- A quality core vaccine that protects against feline rhinotracheitis, feline panleukopenia virus (FPV), and feline calicivirus (FCV), in addition to providing extenseive 2-year coverage for FeLV.
- Nobivac Feline 1-HCP has been shown block the replication of canine parvovirus (CPV) in cats.1
- Evidence shows that CPV-2a, CPV-2b, and CPV-2c isolates can replicate in cats, producing clinical signs of feline panleukopenia.2-4
- The only feline leukemia vaccine labeled to prevent persistent viremia for 2 years after vaccination.5
- Superior Efficacy demonstrated vs. multiple FeLV vaccines.6-7
- The ONLY USDA-licensed 2-year Duration of Immunity (DOI) FeLV vaccine (Ideal for adherence to AAFP guidelines)1,5,8
- The oNLY vaccine to demonstrate efficacy over the long-term in a co-mingling study mimicking real life conditions.1
- Proven safety profile-99% reaction-free in ongoing surveillance involving millions of doses.1
- The optimal choice for both indoor and outdoor cats of all ages and for all cats under 1 year of age
- Indications
- Approved for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses
- Approved as an aid in the prevention of lymphoid tumors caused by, and diseases associated with feline leukemia virus (FeLV) infection
- Vaccination with this product prevents persistent viremia in cats exposed to virulent FeLV
- Recommended for use in healthy cats 9 weeks of age or older
Nobivac is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.
Directions
For cats 9 weeks of age or older:
Subcutaneous or intramuscular injection
Initial 1ml dose administered at 9 weeks of age or older
Second 1ml dose administered 3 to 4 weeks later
Revaccination every 2 years with 1 dose of Nobivac Feline 1-HCP+FeLV is recommended
Revaccination in the intervening years with NObivac Feline 1-HCP is recommended
PRECAUTIONS:Store at 2°-7°
Do not freeze.
Do not mix with other vaccines.
Use new, non-chemically sterilized needles and syringes.
Burn vaccine container and all unused contents.
WARNINGS:Contains gentamicin and amphotericin B as preservative.
Vaccinate only health, non-parasitized dogs.
Do not vaccinate pregnant bitches.
The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
The age at which maternal antibody for canine parvovirus no longer interferes with the development of active immunity varies according to the bitch's titer and quantity of colostral antibodies absorbed by the puppy.
-
Safety Information
- 98.8% reaction-free in field safety studies
- 99.99% reaction-free in ongoing surveillance involving millions of doses.1
- Study showed no signs of inflammation or adjuvant at Day 21 after subcutaneous vaccination.1
- Two-year DOI means fewer vaccinations
PRECAUTIONS:
WARNINGS:
